Canaccord Genuity Downgrades Repro Med Systems (KRMD) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts KRMD Hot Sheet
Price: $3.28 +5.81%
Rating Summary:
4 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 28 | New: 13
Rating Summary:
4 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 28 | New: 13
Join SI Premium – FREE
Canaccord Genuity analyst Kyle Rose downgraded Repro Med Systems (NASDAQ: KRMD) from Buy to Hold.
For an analyst ratings summary and ratings history on Repro Med Systems click here. For more ratings news on Repro Med Systems click here.
Shares of Repro Med Systems closed at $5.18 yesterday.
You May Also Be Interested In
- Raymond James Double Downgrades Aardvark Therapeutics Inc (AARD) to Market Perform
- KeyBanc Downgrades Vistra Energy (VST) to Sector Weight
- JPMorgan Downgrades Beijing Kingsoft Office Software Inc (688111:CH) to Neutral
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
